Attached files
| file | filename |
|---|---|
| S-1 - FORM S-1 - Inhibitor Therapeutics, Inc. | d783002ds1.htm |
| EX-23.2 - CONSENT OF PBMARES, LLP - Inhibitor Therapeutics, Inc. | d783002dex232.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference of our firm under the caption “Experts” in this Registration Statement on Form S-1 and related prospectuses of Hedgepath Pharmaceuticals, Inc. dated September 12, 2014 and to the inclusion therein of our report, dated April 15, 2014, with respect to the financial statements of HedgePath Pharmaceuticals, Inc. included in its Form 10-K filed April 15, 2014 with the Securities and Exchange Commission.
/s/ CHERRY BEKAERT LLP
Tampa, Florida
September 17, 2014